Unlock instant, AI-driven research and patent intelligence for your innovation.

Bicyclic 6-alkylidene-penems as beta-lactamase inhibitors

a technology of beta-lactamase and bicyclic sulfonate, which is applied in the direction of antibacterial agents, drug compositions, biocide, etc., can solve the problems of loss of antibacterial activity, compound ineffectiveness against class c producing organisms, and damage to the effective treatment of bacterial infections

Inactive Publication Date: 2006-09-28
WYETH LLC
View PDF13 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent is about certain compounds that can treat bacterial infections caused by β-lactam antibiotics. These compounds are broad spectrum β-lactamase inhibitors, which means they can stop the action of enzymes that break down antibiotics. By combining these compounds with β-lactam antibiotics, they can effectively treat bacterial infections. The patent describes the background and development of these compounds and their use in combination with β-lactam antibiotics.

Problems solved by technology

However, the development of resistance to β-lactam antibiotics by different pathogens has had a damaging effect on maintaining the effective treatment of bacterial infections.
These enzymes degrade the β-lactam antibiotics, resulting in the loss of antibacterial activity.
However, these compounds are ineffective against class C producing organisms.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bicyclic 6-alkylidene-penems as beta-lactamase inhibitors
  • Bicyclic 6-alkylidene-penems as beta-lactamase inhibitors
  • Bicyclic 6-alkylidene-penems as beta-lactamase inhibitors

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of (5R,6Z)-6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

Step 1: Ethyl 5-benzoyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylate

[0262] To a stirred dry DMF (7.3 g, 100 mmol), POCl3 (12.25 g, 80 mmol) was slowly added between 0° C. to 5° C. After the addition the solidified mass was dissolved in CH2Cl2 (20 ml) and stirred at room temperature for 2 hrs. Again the temperature was cooled to 0° C. and 1-benzoyl-4-piperidone in CH2Cl2 was added slowly. After the addition the reaction mixture was stirred at room temperature for 2 hrs and poured over crushed ice and sodium acetate. It was stirred for 30 minutes at room temperature. Extracted with CH2Cl2; washed well with water; dired over anhydrous MgSO4 and concentrated. The crude product was dissolved in CH2Cl2 and ethylmercaptoacetae (9.6 g, 80 mmol) / Et3N (10.1 g, 100 mmol) was added slowly at room temperature. The reaction mixture was re...

example 2

Preparation of (5R),(6Z)-6-(7-Methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-2-ylmethylene)-7-oxo-4-thia-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid, sodium salt

Step 1: Imidazo[1,2-a]pyrazine-2-carboxylic acid ethyl ester

[0268] Ethyl bromopyruvate (62.9 g) was added to the DME (258 mL) solution of 2-aminopyrazine (24.8 g) at room temperature and stirred for 2.5 h. The reaction mixture was cooled to 0° C. and stirred for 30 min to afford a pale brown precipitate. The precipitate was filtered and washed with Et2O to give pale brown crystals. The suspension of the precipitate (66.1 g) in EtOH (1.29 L) was heated at reflux temperature to turn to clear solution. After refluxing for 2 h, the reaction mixture was concentrated under reduced pressure, then mixed with CHCl3 and saturated NaHCO3aq. The mixture was filtered through a pad of Celite and the separated organic layer was dried (MgSO4) and filtered. The filtrate was concentrated under reduced pressure. The residue was applied ...

example 3

Preparation of (5R),(6Z)-7-Oxo-6-(5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-2-ylmethylene)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, sodium salt

2-Ketopiperazine

[0279] 2-Ketopiperazine may be prepared according to procedures in U.S. Pat. No. 5,629,322.

Step 1: 4-p-Nitrobenzyloxycarbonyl-2-ketopiperazine

[0280] The 48.7% solution of p-nitrobenzyloxycarbonyl chloride in 1,4-Dioxane (10.7 mL) was added to the dichloromethane (110 mL) solution of 2-Ketopiperazine (2.21 g) and diisopropylethylamine (4.6 mL) at 0° C. and stirred for 0.5 h at 0° C. Water (300 mL) was added to the reaction mixture, and extracted with dichloromethane (3×100 mL). The organic layer was dried (MgSO4) and filtered. The filtrate was concentrated under reduce pressure. The residue was applied to silica gel column chromatography, eluted with CHCl3-methanol (30:1), and the title compound was obtained as white solid (7.1 g, quant.).

[0281]1H NMR (d, CDCl3)δ 3.42-3.45 (m, 2H), 3.74 (t, 2H, J=5.4 Hz), 4.1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
volumeaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

The present invention provides a compound of formula I, pharmaceutical compositions and the use thereof for the treatment of bacterial infection or disease in a patient in need thereof.

Description

[0001] This application is a divisional of copending application Ser. No. 10 / 427,380, filed May 1, 2003, which claims priority from provisional application Ser. No. 60 / 377,052, filed May 1, 2002, the entire disclosures of which are hereby incorporated by reference.FIELD OF INVENTION [0002] This invention relates to certain bicyclic 6-alkylidene penems which act as a broad spectrum β-lactamase inhibitors. β-Lactamases hydrolyze β-lactam antibiotics, and as such serve as the primary cause of bacterial resistance. The compounds of the present invention when combined with β-lactam antibiotics will provide an effective treatment against life threatening bacterial infections. BACKGROUND OF THE INVENTION [0003] Penicillins and cephalosporins are the most frequently and widely used β-lactam antibiotics in the clinic. However, the development of resistance to β-lactam antibiotics by different pathogens has had a damaging effect on maintaining the effective treatment of bacterial infections. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/424A61K31/43C07D499/00C07D499/897A61K31/431A61K31/4365A61K31/437A61K31/4985A61K31/5383A61K31/542A61P31/04A61P43/00C07D499/88C07D503/00C07D519/00C07D519/06
CPCC07D499/861C07D519/00C07D503/00C07D499/88A61P31/04A61P43/00C07D499/881
Inventor VENKATESAN, ARANAPAKAM MUDUMBAIMANSOUR, TAREK SUBAYLABE, TAKAOYAMAMURA, ITSUKITAKASAKI, TSUYOSHIAGARWAL, ATULSANTOS, OSVALDO DOSSUM, FUK-WAHLIN, YANG-I
Owner WYETH LLC